New Zealand markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
108.87+2.71 (+2.55%)
At close: 04:04PM EDT
108.87 0.00 (0.00%)
After hours: 04:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.43B
Enterprise value 27.37B
Trailing P/E 76.29
Forward P/E 15.60
PEG ratio (5-yr expected) 3.52
Price/sales (ttm)2.72
Price/book (mrq)1.78
Enterprise value/revenue 3.47
Enterprise value/EBITDA 17.45

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-31.50%
S&P500 52-week change 3-8.83%
52-week high 3161.26
52-week low 3101.22
50-day moving average 3118.11
200-day moving average 3125.27

Share statistics

Avg vol (3-month) 31.38M
Avg vol (10-day) 31.57M
Shares outstanding 5209.58M
Implied shares outstanding 6N/A
Float 8209.29M
% held by insiders 15.48%
% held by institutions 193.21%
Shares short (30 May 2022) 42.15M
Short ratio (30 May 2022) 41.6
Short % of float (30 May 2022) 41.14%
Short % of shares outstanding (30 May 2022) 41.02%
Shares short (prior month 28 Apr 2022) 43.51M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.94%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.90%
5-year average dividend yield 40.75
Payout ratio 471.64%
Dividend date 328 Jul 2022
Ex-dividend date 423 Jun 2022
Last split factor 2103:100
Last split date 328 Feb 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 2.76%
Operating margin (ttm)16.47%

Management effectiveness

Return on assets (ttm)3.56%
Return on equity (ttm)2.31%

Income statement

Revenue (ttm)7.9B
Revenue per share (ttm)37.81
Quarterly revenue growth (yoy)3.90%
Gross profit (ttm)5.54B
EBITDA 2.37B
Net income avi to common (ttm)281.2M
Diluted EPS (ttm)1.04
Quarterly earnings growth (yoy)-92.80%

Balance sheet

Total cash (mrq)461.2M
Total cash per share (mrq)2.2
Total debt (mrq)6.38B
Total debt/equity (mrq)53.10
Current ratio (mrq)1.69
Book value per share (mrq)57.33

Cash flow statement

Operating cash flow (ttm)1.49B
Levered free cash flow (ttm)1.47B